Mintz advised Lisata Therapeutics, a clinical-stage pharmaceutical company, in its acquisition of Marea Therapeutics and the concurrent $225 million private placement financing.

The transaction combines Lisata with Marea, a clinical-stage biotechnology company developing therapies for cardioendocrine diseases.

The Mintz corporate team included Jeffrey Schultz, Daniel Bagliebter, Jason Miller, and Patricia Garza Gonzalez. Specialist support was provided by Jason Vinga, Anne Bruno, Page Hubben, Tom Pagliarini, Michelle Capezza, Timothy Santoli, Liz Allison, Joanne Hawana, Benjamin Zegarelli, and Jenny Chen, PhD.

Read Lisata Therapeutics’ press release here.